<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">INSULIN ZINC SUSPENSION, EXTENDED (ULTRALENTE)</span><br/>(in'su-lin)<br/><span class="topboxtradename">Humulin U, </span><span class="topboxtradename">Ultralente, </span><span class="topboxtradename">Ultralente Insulin<br/></span><b>Classifications:</b> <span class="classification">hormone and synthetic substitute</span>; <span class="classification">antidiabetic agent</span><br/><b>Prototype: </b>Insulin Injection<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 units/mL</p>
<h1><a name="action">Actions</a></h1>
<p>Long-acting cloudy suspension of insulin modified by addition of zinc chloride. Large particle size and high zinc content
         delay absorption and prolong action. Obtained from pork pancreas. Incidence of allergic reactions is low. Similar to protamine
         zinc insulin suspension (PZI) in actions and indications.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>It lowers blood glucose levels by increasing peripheral glucose uptake, especially by skeletal muscle and fat tissue, and
         by inhibiting the liver from changing glycogen to glucose. Usually administered in combination with a shorter acting insulin
         preparation.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Diabetes mellitus type 1.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>During episodes of hypoglycemia or in patients sensitive to any ingredient in the formulation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>In insulin resistant patients, hyperthyroidism or hypothyroidism; lactation, older adults, pregnancy (category B), renal or
         hepatic impairment. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Diabetes Mellitus</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM/SC</span> Individualized doses (see <small>INSULIN INJECTION, REGULAR</small>)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Subcutaneous/</span><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give 30 min before breakfast by deep SC injection.</li>
<li>Ensure complete dispersion by mixing thoroughly by gently rotating vial between palms and by inverting it end-to-end several
            times. Do not shake.
         </li>
<li> 				Note: Ultralente may be mixed with Semilente but not with other modified insulin preparations. Compatible with regular insulin.
            Do <small>NOT</small> mix insulins unless prescribed by physician. 			
         </li>
<li>Store unopened vial at 2°8° C (36°46° F). Avoid freezing and exposure to extremes in temperature
            or to direct sunlight.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1>(see <small>INSULIN INJECTION, REGULAR</small>). 
      <h1><a name="interactions">Interactions</a></h1>(see <small>INSULIN INJECTION</small>). 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 48 h. <span class="typehead">Peak:</span> 1618 h. <span class="typehead"> Duration:</span> 36 h. <span class="typehead">Metabolism:</span> Metabolized in liver and kidney. <span class="typehead">Elimination:</span> Half-Life: Up to 13 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p>(see <small>INSULIN INJECTION, REGULAR</small>)
      </p>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Be aware that restlessness or profuse sweating during sleep are S&amp;S of hypoglycemia. Notify physician. Treat by eating soluble
            carbohydrate (orange juice, sugar, honey) plus a slowly digestible carbohydrate (bread, crackers). Supplemental feedings may
            be prescribed.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>